← Back to graph

Prescription

adalimumab-afzb Abrilada

Selected indexed studies

Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis. (Rheumatol Ther, 2022) [PMID:35304684]

_Worker-drafted node — pending editorial review._

Connections

No connections recorded yet.

Sources

Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis. (2022) pubmed

Local graph